Title |
Importance of pharmacogenetics in the treatment of children with attention deficit hyperactive disorder: a case report
|
---|---|
Published in |
Pharmacogenomics and Personalized Medicine, January 2013
|
DOI | 10.2147/pgpm.s36782 |
Pubmed ID | |
Authors |
Teerarat Tan-kam, Chutamanee Suthisisang, Chosita Pavasuthipaisit, Penkhae Limsila, Apichaya Puangpetch, Chonlaphat Sukasem |
Abstract |
This case report highlights the importance of pharmacogenetic testing in the treatment of attention deficit hyperactive disorder (ADHD). A 6-year-old boy diagnosed with ADHD was prescribed methylphenidate 5 mg twice daily (7 am and noon) and the family was compliant with administration of this medication. On the first day of treatment, the patient had an adverse reaction, becoming disobedient, more mischievous, erratic, resistant to discipline, would not go to sleep until midnight, and had a poor appetite. The All-In-One PGX (All-In-One Pharmacogenetics for Antipsychotics test for CYP2D6, CYP2C19, and CYP2C9) was performed using microarray-based and real-time polymerase chain reaction techniques. The genotype of our patient was identified to be CYP2D6*2/*10, with isoforms of the enzyme consistent with a predicted cytochrome P450 2D6 intermediate metabolizer phenotype. Consequently, the physician adjusted the methylphenidate dose to 2.5 mg once daily in the morning. At this dosage, the patient had a good response without any further adverse reactions. Pharmacogenetic testing should be included in the management plan for ADHD. In this case, cooperation between the medical team and the patients' relatives was key to successful treatment. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Mexico | 1 | 20% |
Canada | 1 | 20% |
United States | 1 | 20% |
Unknown | 2 | 40% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Practitioners (doctors, other healthcare professionals) | 2 | 40% |
Members of the public | 2 | 40% |
Scientists | 1 | 20% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 2% |
Brazil | 1 | 2% |
Unknown | 55 | 96% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 10 | 18% |
Student > Master | 7 | 12% |
Student > Bachelor | 7 | 12% |
Professor > Associate Professor | 6 | 11% |
Student > Ph. D. Student | 4 | 7% |
Other | 12 | 21% |
Unknown | 11 | 19% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 17 | 30% |
Psychology | 7 | 12% |
Pharmacology, Toxicology and Pharmaceutical Science | 6 | 11% |
Nursing and Health Professions | 5 | 9% |
Chemistry | 3 | 5% |
Other | 7 | 12% |
Unknown | 12 | 21% |